OTC - ACTIVE INGREDIENT SECTION
DRUG FACTS
Active Ingredients........... Salicylic Acid 2%
DRUG FACTS
Active Ingredients........... Salicylic Acid 2%
Purpose ............... Acne Treatment
Uses: For the treatment of acne. Penetrates pores to eliminate most acne blemishes, whiteheads & blackheads. Helps prevent new acne blemishes, whiteheads & blackheads.
Directions: Lather with water and massage onto affected areas. Let sit for 30 to 60 seconds to maximize results. Rinse clean with warm water.
Warnings: For external use only. When using this product skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
Keep out of the reach of children. If swallowed get medical help or contact a Poison Control center right away.
INACTIVE INGREDIENTS: WATER/AQUA/EAU, SODIUM C14-16 OLEFIN SULFONATE, COCAMIDOPROPYL HYDROXYSULTAINE, DISTEARETH-75 IPDI, PROPANEDIOL, SODIUM LAUROAMPHOACETATE, GLYCERIN, GLYCOLIC ACID, COCAMIDOPROPYL BETAINE, PHENOXYETHANOL, SODIUM CHLORIDE, GLUCO-NOLACTONE, SODIUM HYDROXIDE, SODIUM GLUCONATE
Geologie
CLEAR SYSTEM
Acne Control
Superclean
Body Wash
250 mL 8.4 fl oz
Geologie.com
Distributed by Geologie
New York, NY 10163
res
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 54111-170 | 54111-170-50 |
Every source-derived ingredient row is available through these pages.
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 2 | 2024-12-27 | full-release | 2026-06-01 00:48:57 |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acne Control Superclean Body Wash AHA BHA Formula | SALICYLIC ACID | Bentley Laboratories, LLC | 16fd3343-d044-4f6b-af1a-30bc32ce2041 | 2026-10-30 | Warnings | 54111-170-50 54111-170 54111017050 b515c49b-5f62-4992-9b4f-05baa63a24b0 16fd3343-d044-4f6b-af1a-30bc32ce2041 |
Adverse event summaries are temporarily unavailable. Other product information remains available.